The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.20
Bid: 68.20
Ask: 69.00
Change: 0.20 (0.29%)
Spread: 0.80 (1.173%)
Open: 69.40
High: 69.40
Low: 68.20
Prev. Close: 68.00
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Placing

25 Jun 2019 08:39

RNS Number : 2546D
GCP Asset Backed Income Fund Ltd
25 June 2019
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR IN OR INTO CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

25 June 2019

GCP Asset Backed Income Fund Limited

("GCP Asset Backed" or the "Company")

LEI 213800FBBZCQMP73A815

Result of Placing

On 23 May 2019, GCP Asset Backed, which invests in asset backed loans, announced details of a placing of up to 63,668,978 new ordinary shares (the "New Shares") at a price of 105.00 pence per New Share (the "Placing").

Further to that announcement the Board is pleased to announce that the Company has received applications in respect of 60,317,181 New Shares, raising gross proceeds of £63.3 million for the Company.

The net proceeds of the Placing will be used to repay c.£43 million drawn under the Company's revolving credit facility and continue to take advantage of a pipeline of attractive investment opportunities which have been identified by Gravis Capital Management Limited (the "Investment Manager"). 

Application has been made for all of the New Shares to be admitted to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities ("Admission"). It is expected that Admission will take effect, and dealings in the New Shares will commence, at 8.00 a.m. (London time) on 27 June 2019.

Share certificates in respect of the New Shares are expected to be despatched in the week commencing 1 July 2019 or as soon as possible thereafter.

Immediately following Admission, the Company will have 440,863,028 ordinary shares in issue and therefore the total voting rights in the Company will be 440,863,028. This figure may be used by shareholders as the denominator for the calculations by which they may determine whether or not they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

For further information, please contact:

Gravis Capital Management Limited +44 (0) 20 3405 8500

David Conlon

david.conlon@graviscapital.com

 

Dion Di Miceli

dion.dimiceli@graviscapital.com

 

 

 

 

Cenkos Securities plc

 

+44 (0)20 7397 8900

Tom Scrivens

tscrivens@cenkos.com

 

Oliver Packard

opackard@cenkos.com

 

Sapna Shah

sshah@cenkos.com

 

Notes to Editors

The Company is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

Important Information

The content of this announcement has been prepared by, and is the sole responsibility of, GCP Asset Backed.

The Company is a registered closed-ended limited liability company incorporated in Jersey under the Companies (Jersey) Law 1991, as amended, on 7 September 2015 with registered number 119412. The Company is regulated by the Jersey Financial Services Commission (the "JFSC"). The JFSC is protected by both the Collective Investment Funds (Jersey) Law 1988 and the Financial Services (Jersey) Law 1998, as amended, against liability arising from the discharge of its functions under such laws. The JFSC has not reviewed or approved this announcement.

No representation or warranty, express or implied, is made or given by or on behalf of the Company, Cenkos Securities plc ("Cenkos"), or the Investment Manager or any of their respective directors, officers, employees, agents, affiliates or advisers or any other person (whether or not referred to in this announcement) as to or in relation to the accuracy, completeness or fairness of the information contained herein or any other written or oral information made available to or publicly available to an interested party or their advisers and no responsibility or liability is accepted by any of them for any such information or opinions.

Cenkos, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as sole placing agent for the Company and for no-one else in connection with the Placing and the contents of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients, nor for providing advice in connection with the Placing. Cenkos is not responsible for the contents of this announcement or any other matter referred to herein. This does not limit or exclude any responsibilities which Cenkos may have under FSMA or the regulatory regime established thereunder or under the regulatory regime of any other jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIFMGZVNDVGLZM
Date   Source Headline
29th Apr 20227:00 amRNSDividend Declaration
29th Apr 20227:00 amRNSInvestor Report at 31 March 2022
20th Apr 20227:00 amRNSNet Asset Value and Investment Update
6th Apr 20227:00 amRNSNotice of Annual General Meeting
24th Mar 20227:00 amRNSAnnual Report & Financial Statements
25th Feb 20227:00 amRNSCo-living Group Loan Update
3rd Feb 20227:00 amRNSCo-living Group Loan Update
31st Jan 20227:00 amRNSInvestor Report at 31 December 2021
27th Jan 20227:00 amRNSDividend Declaration
25th Jan 20227:00 amRNSNet Asset Value and Investment Update
22nd Dec 20219:03 amRNSCo-Living 2021 Year End Update
3rd Nov 20217:00 amRNSDividend Declaration
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
15th Oct 20217:00 amRNSNet Asset Value and Investment Update
28th Sep 20217:00 amRNSHalf-year Report
16th Sep 20217:00 amRNSCo-living Group Loan Update
13th Sep 20217:00 amRNSCo-living Group Loan Update and Net Asset Value
20th Aug 20217:00 amRNSExtension to term of Revolving Credit Facility
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021
22nd Jul 20217:00 amRNSDividend Declaration
15th Jul 20217:00 amRNSNet Asset Value and Investment Update
17th May 20212:13 pmRNSResults of Annual General Meeting
4th May 20217:00 amRNSInvestor Report at 31 March 2021
29th Apr 20215:42 pmRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSDividend Declaration
20th Apr 20217:00 amRNSNet Asset Value and Investment Update
16th Apr 20217:00 amRNSNotice of Annual General Meeting
31st Mar 20217:00 amRNSTotal Voting Rights
23rd Mar 20217:00 amRNSAnnual Report & Financial Statements
18th Mar 20217:00 amRNSTransaction in Own Shares
15th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSTransaction in Own Shares
10th Mar 20217:00 amRNSTransaction in Own Shares
8th Mar 20217:00 amRNSCompliance with Market Abuse Regulation
29th Jan 20217:00 amRNSInvestor Report at 31 December 2020
26th Jan 20217:00 amRNSDividend Declaration & Scrip Dividend Suspension
18th Jan 20217:00 amRNSNet Asset Value and Investment Update
4th Dec 20207:00 amRNSInvestment Manager change of control
30th Nov 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSSpecial Dividend Declaration
5th Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSInvestor Report at 30 September 2020
30th Oct 20207:00 amRNSTransaction in Own Shares
29th Oct 20207:00 amRNSTransaction in Own Shares
28th Oct 20207:00 amRNSTransaction in Own Shares
19th Oct 20207:00 amRNSDividend Declaration & Scrip Dividend Suspension
19th Oct 20207:00 amRNSTransaction in Own Shares
16th Oct 20207:00 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value and Investment Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.